TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ENTA

Enanta Pharmaceuticals Inc

Healthcare · Biotechnology

12.20$ -2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Enanta Pharmaceuticals Inc (ENTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 281 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENTA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
155 246 281 327 414 490 491 441 381 462 377 281
108 171 232 238 380 402 437 319 312 423 300 204
31 22 17 66 64 51 87 57 44 85 37 32
91 145 210 224 309 335 387 244 249 370 248 189
4.5 16 13 11 67 51 23 61 49 40 39 6.9
0.0 0.0 0.0 0.0 0.0 -37
1.8 5.9 8.0 8.0 8.4 11 8.6 11 30
0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
6.8 9.9 11 25 21 27 35 41 59 246 248 216
4.7 6.7 7.9 21 16 23 24 36 30 63 58 49
0.2 0.1 0.1 0.1 4.3 4.2 2.9 5.3 36 34
1.9 1.5 3.4 3.7 4.7 6.7 5.7 9.5 6.0 4.1 8.0 1.9
0.0 0.2 0.2 0.8 1.6 1.6
149 236 270 302 394 462 456 399 321 217 129 65
-73 6.0 28 45 117 164 128 49 -73 -207 -323 -405
19 19 19 19 21 21 20 20 21 21 21 21

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?